Skip to content

Exagen Inc. XGN Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$3.97M-5.7%-$4.67M-24.2%-$7.09M-41.0%-$4.44M-49.7%-$3.75M-11.7%
$655K+57.1%$705K+62.8%$593K+173%$443K-20.9%$417K-24.6%
-$10.42M+2.4%-$3.01M-$2.89M-18.9%-$10.67M-18.0%
$228K+102%$44K-69.9%$275K+87.1%$209K+53.7%$113K+31.4%
-$228K-113%-$35K+76.0%-$275K-87.1%-$209K-53.7%-$107K-24.4%
$168K+57.0%$165K$162K$158K+343%$107K+64.6%
-$62K+3.1%$0+100%$2.95M+2,538%$21.93M+9,805%-$64K+36.0%
-$10.71M+1.2%$5.62M+330%$18.84M+776%-$10.84M-17.5%
-$10.65M+1.3%-$3.06M-$3.09M-20.8%-$10.78M-18.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Exagen Inc. generate?
Exagen Inc. (XGN) generated -$27.0M in operating cash flow over the trailing twelve months.
What is Exagen Inc.'s free cash flow?
After $756.0K of capital expenditures, Exagen Inc.'s free cash flow was -$27.6M over the trailing twelve months, down 96.9% year over year.
Where does Exagen Inc.'s cash flow data come from?
Every line is extracted from Exagen Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.